Skip to main content

Table 5 Characteristics of patients following initial TACE with AFP ≥ 200 ng/ml vs. < 200 ng/ml

From: Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation

Repeat serum AFP subgroup n = 177     
VariablenAFP < 200 ng/mlnAFP ≥ 200 ng/mlP value
Pre-TACE, % (n)
 Caucasian14783.7% (123)3063.3% (19)0.011
 HCV14741.5% (61)3070% (21)0.004
 HBV14717.7% (26)3033.3% (10)0.05
 T2DM14734.7% (51)3016.7% (5)0.05
 BCLC stage C1472% (3)3013.3% (4)0.017
 Macrovascular invasion1471.4% (2)3010% (3)0.035
 tumour size, (cm), mean (SD)1473.84 (2.55)305.64 (3.89)0.002
Post initial TACE, median (IQR)
 Neutrophils, x10^9/L912.9 [2.3-3.72]234.2 [2.9-5.1]0.001
 ALT, U/L14638.5 [24-72]2965 [34-100]0.03
 Na, mmol/L145138 [136-140]28137 [135-139]0.048